Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial. 2008

Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
University Hospitals Case Medical Center, Division of Gynecologic Oncology, 11100 Euclid Avenue, Room 7128, Cleveland, Ohio 44106, USA. vivian.vongruenigen@UHhospitals.org

OBJECTIVE The majority of endometrial cancer survivors (ECS) are obese and at risk for premature death. The purpose of this study was to assess feasibility of a lifestyle intervention program for promoting weight loss, change in eating behaviors, and increased physical activity in obese ECS. METHODS Early stage ECS (n=45) were randomized to a 6-month lifestyle intervention (LI; n=23) or usual care (UC; n=22). The LI group received group and individual counseling for 6 months. The primary endpoint was weight change. Secondary endpoints were physical activity, [Leisure score index (LSI)] and nutrient intake (3-day food records). Quantitative vitamin C and folate intake were used to assess fruit/vegetable intake. RESULTS Recruitment was 29%, adherence (LI group) was 73% and 84% of participants completed follow-up assessments. At 12 months, the intervention group lost 3.5 kg compared to a 1.4 kg gain in the control group [mean difference=-4.9 kg; 95% CI: -9.0 to -0.9 kg; p=.018] and had an increased LSI score of 16.4 versus -1.3 in the control group from baseline [mean group difference=17.8; 95% CI=7.1 to 28.4; p=.002]. There were no differences in vitamin C and folate intake. The LI group had lower intake of kilocalories, although differences were not significant. CONCLUSIONS A lifestyle intervention program in obese ECS is feasible and can result in sustained behavior change and weight loss over a 1-year period.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
September 2017, Integrative cancer therapies,
Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
May 2016, The New England journal of medicine,
Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
January 2016, Nederlands tijdschrift voor geneeskunde,
Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
June 2018, The New England journal of medicine,
Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
June 2010, Archives of internal medicine,
Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
June 2015, Gynecologic oncology,
Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
November 2022, Cancers,
Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
December 2020, Journal of general internal medicine,
Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
July 2016, Annals of family medicine,
Vivian E von Gruenigen, and Kerry S Courneya, and Heidi E Gibbons, and Mary Beth Kavanagh, and Steven E Waggoner, and Edith Lerner
February 2009, Annals of internal medicine,
Copied contents to your clipboard!